(1'R,3'S,4'R)-2-AMINO-6-CHLORO-9-[3'-ACETOXY-4'-(ACETOXYMETHYL)-CYCLOPENTAN-1'-YL]-PURINE
Compound with spectra: 1 NMR
![(1'R,3'S,4'R)-2-AMINO-6-CHLORO-9-[3'-ACETOXY-4'-(ACETOXYMETHYL)-CYCLOPENTAN-1'-YL]-PURINE](/api/compound/G4k71kHqjS9.png?ph=true&h=300&w=458 "(1'R,3'S,4'R)-2-AMINO-6-CHLORO-9-[3'-ACETOXY-4'-(ACETOXYMETHYL)-CYCLOPENTAN-1'-YL]-PURINE")
| SpectraBase Compound ID | G4k71kHqjS9 |
|---|---|
| InChI | InChI=1S/C15H18ClN5O4/c1-7(22)24-5-9-3-10(4-11(9)25-8(2)23)21-6-18-12-13(16)19-15(17)20-14(12)21/h6,9-11H,3-5H2,1-2H3,(H2,17,19,20)/t9-,10-,11+/m0/s1 |
| InChIKey | CSAZOUFTZCXMLF-GARJFASQSA-N |
| Mol Weight | 367.79 g/mol |
| Molecular Formula | C15H18ClN5O4 |
| Exact Mass | 367.104732 g/mol |
| Enantiomer InChIKey | CSAZOUFTZCXMLF-MXWKQRLJSA-N |
| Copyright | Copyright © 2016-2024 W. Robien, Inst. of Org. Chem., Univ. of Vienna. All Rights Reserved. |
|---|---|
| Solvent | CDCl3 |
17;(1R,2S,4S)-4-(9H-ADENIN-9-YL)-2-[(TRIPHENYLMETHOXY)-METHYL]-CYCLOPENT-1-YL-ACETATE;9-[(1S,3R,4S)-3-ACETOXY-4-[(TRIPHENYLMETHOXY)-METHYL]-CYCLOPENT-1-YL]-9H-
(1'R,4'R)-2-AMINO-6-CHLORO-9-[4'-(TRIPHENYLMETHOXYMETHYL)-CYCLOPENT-2'-EN-1'-YL]-PURINE
2-AMINO-6-CHLORO-9-[(1'R,4'S)-4'-HYDROXYMETHYL-4'-NONYL-2'-CYCLOPENTEN-1'-YL]-9H-PURINE
9-(2-DEOXY-BETA-D-ERYTHRO-PENTOFURANOSYL)-9H-PURINE-2,6-DIAMINE;2-AMINO-2'-DEOXYADENOSINE
2-Amino-2'-deoxyadenosine
Methyl [4-(6-amino-9H-purin-9-yl)-2-(([tert-butyl(diphenyl)silyl]oxy)methyl)cyclopentyl]acetate
2-Amino-9-(4-hydroxy-5-hydroxymethyl-tetrahydro-furan-2-yl)-9H-purin-6-ol
Guanosine, 2'-deoxy-
9-(2-DEOXY-BETA-D-THREO-PENTOFURANOSYL)-GUANINE
9-[(1'.beta.,3'a.alpha.,4'.beta.)-4'-(Dihydroxyphosphorylmethoxy)-3'-hydroxycyclopentyl}adenine 3',4'-cyclic acid ester
| Title | Journal or Book | Year |
|---|---|---|
| Facile conversion of 4-endo-hydroxy-2-oxabicyclo[3.3.0]oct-7-en-3-one into carbocyclic 2′-deoxyribonucleoside analogues | Journal of the Chemical Society, Perkin Transactions 1 | 1999 |